T. Rowe Price Investment Management
ENFN

T. Rowe Price Investment Management’s Enfusion, Inc. ENFN Stock Holding History

T. Rowe Price Investment Management’s Portfolio ENFN Stock Details ENFN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,157,248
Closed -$11.9M – 705
2024
Q4 		$11.9M Sell
1,157,248
-169,579
-13% -$1.64M 0.01% 545
2024
Q3 		$12.6M Sell
1,326,827
-44,645
-3% -$385K 0.01% 541
2024
Q2 		$11.7M Buy
1,371,472
+491,750
+56% +$4.5M 0.01% 540
2024
Q1 		$8.14M Buy
879,722
+3,881
+0.4% +$34.1K 0.01% 548
2023
Q4 		$8.5M Buy
+875,841
New +$8.18M 0.01% 519

Other funds holding ENFN

FMC
FTV Management Company San Francisco, California $541M AUM 34.37% 1-Year Est. Return
IC
Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
LECM
Lead Edge Capital Management New York $408M AUM 4.05% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

T. Rowe Price Investment Management's ENFN Position: Q1 2025 in Review

T. Rowe Price Investment Management sold out of Enfusion, Inc. (ENFN) in Q1 2025, closing a stake of 1,157,248 shares — an estimated $11.9M sold.

T. Rowe Price Investment Management first reported a position in ENFN in Q4 2023 and held it in 5 quarters. The position peaked at $12.6M in Q3 2024. 132 funds tracked by Wall St. Rank hold ENFN as of Q1 2025.

  • T. Rowe Price Investment Management reported no remaining Enfusion, Inc. position as of Q1 2025 after selling out during the quarter.
  • T. Rowe Price Investment Management sold 1,157,248 Enfusion, Inc. shares in Q1 2025, an estimated $11.9M.
  • T. Rowe Price Investment Management first reported a position in Enfusion, Inc. in Q4 2023 and held it in 5 quarters.
  • T. Rowe Price Investment Management's Enfusion, Inc. position peaked at $12.6M in Q3 2024.
  • 132 funds tracked by Wall St. Rank held Enfusion, Inc. as of Q1 2025.

Based on T. Rowe Price Investment Management's 13F filing for Q1 2025, filed 14 May 2025.